{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:49:49Z","timestamp":1785826189820,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 20228YKCF2_001"],"award-info":[{"award-number":["PRIN 20228YKCF2_001"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007385","name":"Fondazione Cassa di Risparmio in Bologna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Ovarian cancer (OC) is a highly aggressive malignancy characterized by early dissemination of cancer cells from the surface of the ovary to the peritoneum. To gain a deeper understanding of the mechanisms associated with this intraperitoneal spread, we aimed to characterize the role of extracellular vesicles (EVs) in metastatic colonization in OC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>To this purpose, a total of 150 samples of ascitic fluids, blood serum, tumor and normal tissues from 60 OC patients, were extensively analyzed to characterize the EVs released in blood and ascitic fluids of OC patients, in terms of size, expression of superficial epitopes and abundance of miRNAs biocargo.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A statistically significant difference in the size of EVs derived from ascitic fluid and serum was identified. Analysis of surface protein expression highlighted twenty epitopes with a significant difference between the two biological matrices, of which 18 were over- and two were under-expressed in ascitic fluid. With regard to miRNA levels, Principal Component Analysis (PCA) assessed four distinct clusters representing tumor tissue, normal tissue, ascitic fluid, and serum. A prominent difference in circulating miRNAs was observed in serum and ascitic fluid highlighting 98 miRNAs significantly deregulated (<jats:italic>P-adj<\/jats:italic>\u2009&lt;\u20090.05) between the two bodily fluids. Deregulated miRNAs and epitopes underline an enrichment in ascites in components contributing to the metastatic spread.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The results highlight a clear difference between the two biological fluids, suggesting that tumor selectively releases specific EVs populations in serum or ascites. In this context, it seems that ascites-derived EVs play a major role in modulating EMT and metastatic cascade, which is a key feature of OC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s10020-025-01177-7","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T07:44:41Z","timestamp":1745221481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Distinctive features of blood- and ascitic fluid-derived extracellular vesicles in ovarian cancer patients"],"prefix":"10.1186","volume":"31","author":[{"given":"Francesca","family":"Gorini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia Alexandra","family":"Coada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Monesmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"de Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Dondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Di Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Mezzapesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Vannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Melloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Di Corato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierandrea","family":"De Iaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Hrelia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Myriam","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Ravegnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"1177_CR1","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.3390\/cancers15225356","volume":"15","author":"C Bachmann","year":"2023","unstructured":"Bachmann C. New achievements from molecular biology and treatment options for refractory\/relapsed ovarian cancer-a systematic review. Cancers. 2023;15:5356.","journal-title":"Cancers"},{"key":"1177_CR2","doi-asserted-by":"publisher","first-page":"732900","DOI":"10.3389\/fmolb.2021.732900","volume":"8","author":"E Bandini","year":"2021","unstructured":"Bandini E, Rossi T, Scarpi E, et al. Early detection and investigation of extracellular vesicles biomarkers in breast cancer. Front Mol Biosci. 2021;8:732900.","journal-title":"Front Mol Biosci"},{"key":"1177_CR3","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30:836\u201348.","journal-title":"Cancer Cell"},{"key":"1177_CR4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/embor.2010.117","volume":"11","author":"S Brabletz","year":"2010","unstructured":"Brabletz S, Brabletz T. The ZEB\/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? EMBO Rep. 2010;11:670\u20137.","journal-title":"EMBO Rep"},{"key":"1177_CR5","doi-asserted-by":"publisher","first-page":"5874","DOI":"10.3390\/cancers13235874","volume":"13","author":"I Cavallari","year":"2021","unstructured":"Cavallari I, Ciccarese F, Sharova E, et al. The miR-200 family of microRNAs: fine tuners of epithelial-mesenchymal transition and circulating cancer biomarkers. Cancers. 2021;13:5874.","journal-title":"Cancers"},{"key":"1177_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-024-02103-x","volume":"23","author":"W Dai","year":"2024","unstructured":"Dai W, Zhou J, Chen T. Unraveling the extracellular vesicle network: insights into ovarian cancer metastasis and chemoresistance. Mol Cancer. 2024;23:1\u201319.","journal-title":"Mol Cancer"},{"key":"1177_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08870-w","volume":"22","author":"K Ekstr\u00f6m","year":"2022","unstructured":"Ekstr\u00f6m K, Crescitelli R, P\u00e9tursson HI, Johansson J, L\u00e4sser C, Bagge RO. Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer. BMC Cancer. 2022;22:1\u201317.","journal-title":"BMC Cancer"},{"key":"1177_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells9081836","volume":"9","author":"Z Eslami-S","year":"2020","unstructured":"Eslami-S Z, Cort\u00e9s-Hern\u00e1ndez LE, Alix-Panabi\u00e8res C. Epithelial cell adhesion molecule: an anchor to isolate clinically relevant circulating tumor cells. Cells. 2020;9:1\u201317.","journal-title":"Cells"},{"key":"1177_CR9","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3892\/ijo.2017.3948","volume":"50","author":"CP Flores","year":"2017","unstructured":"Flores CP, Garcia-V\u00e1zquez R, Rinc\u00f3n DG, et al. MicroRNAs driving invasion and metastasis in ovarian cancer: Opportunities for translational medicine (Review). Int J Oncol. 2017;50:1461\u201376.","journal-title":"Int J Oncol"},{"key":"1177_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","volume":"123","author":"CE Ford","year":"2020","unstructured":"Ford CE, Werner B, Hacker NF, Warton K. The untapped potential of ascites in ovarian cancer research and treatment. Br J Cancer. 2020;123:9\u201316.","journal-title":"Br J Cancer"},{"key":"1177_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/cells7080093","volume":"7","author":"J Jabalee","year":"2018","unstructured":"Jabalee J, Towle R, Garnis C. The role of extracellular vesicles in cancer: cargo, function, and therapeutic implications. Cells. 2018;7:93.","journal-title":"Cells"},{"key":"1177_CR12","doi-asserted-by":"publisher","first-page":"120011","DOI":"10.1016\/j.cca.2024.120011","volume":"565","author":"Z Jamali","year":"2025","unstructured":"Jamali Z, Razipour M, Zargar M, Ghasemnejad-Berenji H, Akrami SM. Ovarian cancer extracellular vesicle biomarkers. Clin Chim Acta. 2025;565:120011.","journal-title":"Clin Chim Acta"},{"key":"1177_CR13","doi-asserted-by":"publisher","first-page":"14910","DOI":"10.1074\/jbc.C800074200","volume":"283","author":"M Korpal","year":"2008","unstructured":"Korpal M, Lee ES, Hu G, Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008;283:14910\u20134.","journal-title":"J Biol Chem"},{"key":"1177_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-021-00712-9","volume":"7","author":"X Ma","year":"2021","unstructured":"Ma X, Ying Y, Sun J, et al. circKDM4C enhances bladder cancer invasion and metastasis through miR-200bc-3p\/ZEB1 axis. Cell Death Discov. 2021;7:1\u201310.","journal-title":"Cell Death Discov"},{"key":"1177_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-0965-7","volume":"18","author":"S Maacha","year":"2019","unstructured":"Maacha S, Bhat AA, Jimenez L, Raza A, Haris M, Uddin S, Grivel JC. Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance. Mol Cancer. 2019;18:1\u201316.","journal-title":"Mol Cancer"},{"key":"1177_CR16","doi-asserted-by":"publisher","first-page":"016111","DOI":"10.1063\/5.0132254","volume":"7","author":"HM Micek","year":"2023","unstructured":"Micek HM, Rosenstock L, Ma Y, et al. Model of collective detachment in high-grade serous ovarian cancer demonstrates that tumor spheroids produce ECM to support metastatic processes. APL Bioeng. 2023;7:016111.","journal-title":"APL Bioeng"},{"key":"1177_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2478\/raon-2023-0046","volume":"57","author":"S Miceska","year":"2023","unstructured":"Miceska S, Skof E, Bucek S, Kuhar CG, Gasljevic G, Smrkolj S, Prevodnik VK. The prognostic significance of tumor-immune microenvironment in ascites of patients with high-grade serous carcinoma. Radiol Oncol. 2023;57:493\u2013506.","journal-title":"Radiol Oncol"},{"key":"1177_CR18","doi-asserted-by":"publisher","first-page":"6532","DOI":"10.3390\/ijms22126532","volume":"22","author":"S Morand","year":"2021","unstructured":"Morand S, Devanaboyina M, Staats H, Stanbery L, Nemunaitis J. Ovarian cancer immunotherapy and personalized medicine. Int J Mol Sci. 2021;22:6532.","journal-title":"Int J Mol Sci"},{"key":"1177_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ctrv.2011.04.002","volume":"38","author":"C Patriarca","year":"2012","unstructured":"Patriarca C, Macchi RM, Marschner AK, Mellstedt H. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review. Cancer Treat Rev. 2012;38:68\u201375.","journal-title":"Cancer Treat Rev"},{"key":"1177_CR20","doi-asserted-by":"publisher","first-page":"6462","DOI":"10.1038\/s41467-024-50786-z","volume":"15","author":"L Qian","year":"2024","unstructured":"Qian L, Zhu J, Xue Z, et al. Proteomic landscape of epithelial ovarian cancer. Nat Commun. 2024;15:6462.","journal-title":"Nat Commun"},{"key":"1177_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/ijms17020156","volume":"17","author":"G Rinnerthaler","year":"2016","unstructured":"Rinnerthaler G, Hackl H, Gampenrieder SP, et al. miR-16-5p is a stably-expressed housekeeping MicroRNA in breast cancer tissues from primary tumors and from metastatic sites. Int J Mol Sci. 2016;17:156.","journal-title":"Int J Mol Sci"},{"key":"1177_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ygyno.2007.08.064","volume":"107","author":"S Runz","year":"2007","unstructured":"Runz S, Keller S, Rupp C, et al. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol Oncol. 2007;107:563\u201371.","journal-title":"Gynecol Oncol"},{"key":"1177_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41540-023-00309-1","volume":"9","author":"S Shah","year":"2023","unstructured":"Shah S, Philipp LM, Giaimo S, Sebens S, Traulsen A, Raatz M. Understanding and leveraging phenotypic plasticity during metastasis formation. Npj Syst Biol Appl. 2023;9:1\u201311.","journal-title":"Npj Syst Biol Appl"},{"key":"1177_CR24","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1038\/s41467-024-49512-6","volume":"15","author":"VO Shender","year":"2024","unstructured":"Shender VO, Anufrieva KS, Shnaider PV, et al. Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cells. Nat Commun. 2024;15:5237.","journal-title":"Nat Commun"},{"key":"1177_CR25","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1093\/nar\/gkae017","volume":"52","author":"M Suszynska","year":"2024","unstructured":"Suszynska M, Machowska M, Fraszczyk E, Michalczyk M, Philips A, Galka-Marciniak P, Kozlowski P. CMC: Cancer miRNA Census\u2014a list of cancer-related miRNA genes. Nucleic Acids Res. 2024;52:1628\u201344.","journal-title":"Nucleic Acids Res"},{"key":"1177_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/19336918.2020.1732761","volume":"14","author":"Z Tavsan","year":"2020","unstructured":"Tavsan Z, Ayar Kayal\u0131 H. EpCAM-claudin-tetraspanin-modulated ovarian cancer progression and drug resistance. Cell Adh Migr. 2020;14:57\u201368.","journal-title":"Cell Adh Migr"},{"key":"1177_CR27","doi-asserted-by":"publisher","first-page":"81621","DOI":"10.18632\/oncotarget.13154","volume":"7","author":"Y Teng","year":"2016","unstructured":"Teng Y, Su X, Zhang X, et al. miRNA-200a\/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations. Oncotarget. 2016;7:81621\u201333.","journal-title":"Oncotarget"},{"key":"1177_CR28","doi-asserted-by":"publisher","first-page":"108158","DOI":"10.1016\/j.biotechadv.2023.108158","volume":"66","author":"W Thompson","year":"2023","unstructured":"Thompson W, Papoutsakis ET. The role of biomechanical stress in extracellular vesicle formation, composition and activity. Biotechnol Adv. 2023;66:108158.","journal-title":"Biotechnol Adv"},{"key":"1177_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-022-04510-8","volume":"13","author":"W Tian","year":"2022","unstructured":"Tian W, Lei N, Zhou J, et al. Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion. Cell Death Dis. 2022;13:1\u201312.","journal-title":"Cell Death Dis"},{"key":"1177_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1096\/fj.12-218222","volume":"27","author":"V Tirino","year":"2013","unstructured":"Tirino V, Desiderio V, Paino F, et al. Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J. 2013;27:13\u201324.","journal-title":"FASEB J"},{"key":"1177_CR31","doi-asserted-by":"publisher","first-page":"100017","DOI":"10.1016\/j.eurox.2019.100017","volume":"3","author":"W Wang","year":"2019","unstructured":"Wang W, Wu LR, Li C, et al. Five serum microRNAs for detection and predicting of ovarian cancer. Eur J Obstet Gynecol Reprod Biol X. 2019;3:100017.","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"1177_CR32","doi-asserted-by":"publisher","first-page":"215735","DOI":"10.1016\/j.canlet.2022.215735","volume":"542","author":"W Wang","year":"2022","unstructured":"Wang W, Jo HA, Park S, et al. Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer. Cancer Lett. 2022;542:215735.","journal-title":"Cancer Lett"},{"key":"1177_CR33","doi-asserted-by":"publisher","first-page":"378189","DOI":"10.3389\/fimmu.2018.01326","volume":"9","author":"OPB Wiklander","year":"2018","unstructured":"Wiklander OPB, Bostancioglu RB, Welsh JA, et al. Systematic methodological evaluation of a multiplex bead-based flow cytometry assay for detection of extracellular vesicle surface signatures. Front Immunol. 2018;9:378189.","journal-title":"Front Immunol"},{"key":"1177_CR34","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1172\/JCI81129","volume":"126","author":"R Xu","year":"2016","unstructured":"Xu R, Greening DW, Zhu HJ, Takahashi N, Simpson RJ. Extracellular vesicle isolation and characterization: toward clinical application. J Clin Invest. 2016;126:1152\u201362.","journal-title":"J Clin Invest"},{"key":"1177_CR35","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1158\/0008-5472.CAN-13-0023","volume":"73","author":"TL Yeung","year":"2013","unstructured":"Yeung TL, Leung CS, Wong KK, et al. TGF-\u03b2 Modulates ovarian cancer invasion by upregulating CAF-Derived versican in the tumor microenvironment. Cancer Res. 2013;73:5016\u201328.","journal-title":"Cancer Res"},{"key":"1177_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-06434-4","volume":"9","author":"A Yokoi","year":"2018","unstructured":"Yokoi A, Matsuzaki J, Yamamoto Y, et al. Integrated extracellular microRNA profiling for ovarian cancer screening. Nat Commun. 2018;9:1\u201310.","journal-title":"Nat Commun"},{"key":"1177_CR37","first-page":"5601","volume":"17","author":"H Zhang","year":"2019","unstructured":"Zhang H, Xu S, Liu X. MicroRNA profiling of plasma exosomes from patients with ovarian cancer using high-throughput sequencing. Oncol Lett. 2019;17:5601.","journal-title":"Oncol Lett"},{"key":"1177_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3892\/or.2022.8313","volume":"47","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Ding J, Wang Y, He L, Xue F. Tumor microenvironment manipulates chemoresistance in ovarian cancer (Review). Oncol Rep. 2022;47:102.","journal-title":"Oncol Rep"},{"key":"1177_CR39","first-page":"908206","volume":"2012","author":"DX Zhou","year":"2012","unstructured":"Zhou DX, Liu YX, Xue YH. Expression of CD44v6 and Its association with prognosis in epithelial ovarian carcinomas. Patholog Res Int. 2012;2012:908206.","journal-title":"Patholog Res Int"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01177-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01177-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01177-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T07:44:42Z","timestamp":1745221482000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01177-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1177"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01177-7","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients\u2019 samples were collected after providing informed consent and the study was approved by IRB (788\/2021\/Sper\/AOUBo). The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}